Frontlight ResearchEarly access
Taking people in FinlandPhase 2
Tests a new PET scan for spotting colon cancer spread to nearby lymph nodes
Tests a PET scan for finding colon cancer in nearby lymph nodes in adults.
Key facts
- Who runs it
- Turku University Hospital
- Where
- Turku, FinlandSee the site
- Trial code
- Registry title
- Diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 100 people, planned
- Started
- 14 Oct 2024
- Planned end
- 1 Aug 2026
- Type of study
- Interventional
- Record updated
- 20 August 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with primary colon cancer who may have spread to nearby lymph nodes or elsewhere, to test how well an 18F-FAPI-74 PET/CT scan finds it.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Primary colon cancer with suspected spread to lymph nodes in the abdomen on a CT scan before surgery; or cancer spread that may be treatable; or suspected spread or return of cancer on CT and/or a raised CEA level during follow-up
- Biomarker or test result
- A raised carcinoembryonic antigen (CEA) level is one way to join, during cancer follow-up
Main reasons for not taking part
- Disabled people, children, prisoners
- Pregnant or breast-feeding women
- Cannot understand the purpose of the study
- Medical conditions that rule out a whole body PET-CT
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients with primary colon cancer with suspicion of mesenteric lymph node metastases in computed tomography before primary cancer operation
- Patients with primary colon cancer with potentially curable metastases
- Patients with suspected metastasis or local recurrence in computed tomography and/or elevated carcinoembryonic antigen (CEA) in cancer surveillance
- WHO performance score 0-2
- Patient signs informed consent form after receiving written information
Who cannot take part
- Medical conditions prohibiting whole body PET-CT
- Vulnerable study subjects such as described in Finnish law clinical studies (disabled, children, pregnant or breast-feeding women, prisoners) will not be included
- Patient is not able to understand purpose of study
Where in Finland
- Turku University HospitalTurku, FinlandTaking people
About the trial
What the trial wants to find out
To assess the accuracy of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patients with primary colon cancer
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Official title
- Diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer
- Plain-language title
- Tests a new PET scan for spotting colon cancer spread to nearby lymph nodesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 20 August 2024